Seelos Therapeutics (SEEL) Stock Price, News & Analysis
Company Description
Seelos Therapeutics (OTC: SEEL) is classified in the pharmaceutical preparation manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $527.6K, ranking #7,334 among all listed U.S. companies by market cap.
SEEL has declined 99.9% over the past year. Shares last traded at $0.3900.
This page collects what Stock Titan holds for SEEL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Seelos Therapeutics (SEEL) stock last closed at $0.3900. Over the past 12 months, the stock has lost 99.9%. At a market capitalization of $527.6K, SEEL is classified as a micro-cap stock with approximately 436.0K shares outstanding.
SEEL Rankings
Latest News
Seelos Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include stock split, private placement, offering, clinical trial, fda approval. View all SEEL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SEEL Company Profile & Sector Positioning
Seelos Therapeutics (SEEL) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the OTC.